ATE540672T1 - Pharmazeutische zusammensetzung und verfahren - Google Patents

Pharmazeutische zusammensetzung und verfahren

Info

Publication number
ATE540672T1
ATE540672T1 AT08717935T AT08717935T ATE540672T1 AT E540672 T1 ATE540672 T1 AT E540672T1 AT 08717935 T AT08717935 T AT 08717935T AT 08717935 T AT08717935 T AT 08717935T AT E540672 T1 ATE540672 T1 AT E540672T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
AT08717935T
Other languages
English (en)
Inventor
Kondamraj Birudaraj
Michael Thomas Brandl
Shridar Hegde
Felix Sana
Dimitrios Stefanidis
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE540672T1 publication Critical patent/ATE540672T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
AT08717935T 2007-03-29 2008-03-18 Pharmazeutische zusammensetzung und verfahren ATE540672T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92058607P 2007-03-29 2007-03-29
PCT/EP2008/053202 WO2008119659A2 (en) 2007-03-29 2008-03-18 Pharmaceutical composition and process

Publications (1)

Publication Number Publication Date
ATE540672T1 true ATE540672T1 (de) 2012-01-15

Family

ID=39541351

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08717935T ATE540672T1 (de) 2007-03-29 2008-03-18 Pharmazeutische zusammensetzung und verfahren

Country Status (12)

Country Link
US (1) US7893037B2 (de)
EP (1) EP2142178B1 (de)
JP (1) JP2010522705A (de)
CN (1) CN101668515B (de)
AR (1) AR065853A1 (de)
AT (1) ATE540672T1 (de)
CA (1) CA2682638C (de)
CL (1) CL2008000861A1 (de)
ES (1) ES2377760T3 (de)
PE (1) PE20090066A1 (de)
TW (1) TW200909006A (de)
WO (1) WO2008119659A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2455068A1 (de) * 2010-11-09 2012-05-23 F. Hoffmann-La Roche AG Pharmazeutische Zusammensetzung zur Behandlung von HCV-Infektionen
US8889159B2 (en) * 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
BR112017013858A2 (pt) 2014-12-26 2018-02-27 Univ Emory n4-hidroxicitidina e derivados e usos antivirais relacionados aos mesmos
WO2019113462A1 (en) 2017-12-07 2019-06-13 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
CN112957335B (zh) * 2021-02-23 2022-10-04 上海纳为生物技术有限公司 一种乙酰氨基葡萄糖口腔崩解片及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ230497A (en) * 1988-09-02 1992-05-26 Du Pont Layered, granular water-soluble or water-dispersible pesticide
AU2256702A (en) * 2000-12-01 2002-06-11 Kyowa Hakko Kogyo Kk Composition improved in solubility or oral absorbability
TWI332507B (en) * 2002-11-19 2010-11-01 Hoffmann La Roche Antiviral nucleoside derivatives
CN1863812A (zh) * 2003-09-11 2006-11-15 弗·哈夫曼-拉罗切有限公司 多晶型核苷化合物
CA2548376A1 (en) * 2003-12-31 2005-07-21 Pfizer Products Inc. Solid compositions of low-solubility drugs and poloxamers
WO2007068615A2 (en) 2005-12-14 2007-06-21 F. Hoffmann-La Roche Ag Hcv prodrug formulation

Also Published As

Publication number Publication date
CN101668515B (zh) 2013-03-20
ES2377760T3 (es) 2012-03-30
PE20090066A1 (es) 2009-02-13
US7893037B2 (en) 2011-02-22
CA2682638C (en) 2012-07-17
AR065853A1 (es) 2009-07-08
WO2008119659A2 (en) 2008-10-09
JP2010522705A (ja) 2010-07-08
EP2142178B1 (de) 2012-01-11
CL2008000861A1 (es) 2008-11-07
CN101668515A (zh) 2010-03-10
EP2142178A2 (de) 2010-01-13
TW200909006A (en) 2009-03-01
WO2008119659A3 (en) 2009-03-05
US20080260826A1 (en) 2008-10-23
CA2682638A1 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
LTPA2018005I1 (lt) Farmacinė kompozicija
LTPA2018014I1 (lt) Farmacinė kompozicija 514
BRPI0923836A2 (pt) Composições farmacêuticas orais contendo opióide e métodos
DK3345625T3 (da) Farmaceutisk sammensætning og indgivelser deraf
BRPI0715712A2 (pt) Composição farmacêutica
BRPI0719393A2 (pt) Composição farmacêutica
BRPI0721651A2 (pt) Composição farmacêutica
DK2692341T3 (da) Misbrugs-resistent lægemiddelformulering
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
ATE493119T1 (de) Pharmazeutische zusammensetzung
ATE542815T1 (de) Kokristalle und pharmazeutische zusammensetzungen damit
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0720234A2 (pt) Composição farmacêutica
BRPI0905715A2 (pt) Composição farmacêutica e kit de componentes
CR10725A (es) Compuestos de pirazolina y su uso y composiones farmaceuticas
BRPI0908132A2 (pt) Composto de benzodiazepina e composição farmacêutica
LTC2502996I2 (lt) Anti-FGF23 antikūnas ir jį apimanti farmacinė kompozicija
BRPI0819232A2 (pt) composto heterocíclico e composição farmacêutica do mesmo
DK2154966T3 (da) Benzimidazoler og farmaceutiske sammensætninger deraf
DK2285413T3 (da) Farmaceutisk sammensætning
BRPI0817833A2 (pt) Composição farmacêutica antimalárica
ATE530546T1 (de) Kokristalle und pharmazeutische zusammensetzungen damit
BRPI0921313A2 (pt) composição farmaucêutica
DE602008005137D1 (de) Chinolonverbindung und pharmazeutische zusammensetzung
BRPI0821455A2 (pt) Composições farmacêuticas de amlopidina e valsartan